Home>
US Stocks>
Aprea Therapeutics Inc

Aprea Therapeutics Inc share price today

(APRE)

Aprea Therapeutics Inc share price is $3.57 & ₹302.31 as on 10 Dec 2024, 2.30 'hrs' IST

$3.57

▲

0.07

(2%)

Market is closed - opens 8 PM, 10 Dec 2024

View live Aprea Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Aprea Therapeutics Inc from India. Also see the sentimental analysis on Indian investors investing in Aprea Therapeutics Inc. Get details on the Indian mutual funds that are investing in Aprea Therapeutics Inc. Get Analyst recommendations and forecasts along with all the Aprea Therapeutics Inc's financials.

Aprea Therapeutics Inc share price movements

$3.50
$3.78
$3.57
1.96%
Downside
Day's Volatility :7.41%
Upside
5.56%
$2.15
$8.85
$3.57
39.77%
Downside
52 Weeks Volatility :75.7%
Upside
59.65%

Aprea Therapeutics Inc Returns

Period	Aprea Therapeutics Inc	Index (Russel 2000)
3 Months	-3.66%	0.0%
6 Months	-29.15%	0.0%
1 Year	-20.8%	0.0%
3 Years	-95.82%	-20.3%

Aprea Therapeutics Inc Key Statistics

in dollars & INR

Previous Close	$3.5
Open	$3.58
Today's High	$3.78
Today's Low	$3.5
Market Capitalization	$16.9M
Today's Volume	$68.9K
52 Week High	$8.8465
52 Week Low	$2.1501
Revenue TTM	$1.3M
EBITDA	$-14.2M
Earnings Per Share (EPS)	$-2.79
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-50.11%

How to invest in Aprea Therapeutics Inc from India?

It is very easy for Indian residents to invest directly in Aprea Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aprea Therapeutics Inc stock in both rupees (INR) and dollars (USD). Search for Aprea Therapeutics Inc or APRE on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aprea Therapeutics Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aprea Therapeutics Inc shares which would translate to 0.237 fractional shares of Aprea Therapeutics Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Aprea Therapeutics Inc

Period: Sep 10, 2024 to Dec 9, 2024. Change in 30 Days versus previous period

Search volume for Aprea Therapeutics Inc on INDmoney from India has grown in the last 30 days as on Dec 10, 2024. 8% more investors are searching Aprea Therapeutics Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Aprea Therapeutics Inc

AIGH Capital Management, LLC
9.92%
Sio Capital Management, LLC
5.09%
Sphera Funds Management Ltd.
4.97%
Nantahala Capital Management, LLC
3.79%
Vanguard Group Inc
3.20%
Dafna Capital Management LLC
2.52%

Analyst Recommendation on Aprea Therapeutics Inc

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Aprea Therapeutics Inc(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Aprea Therapeutics Inc

What analysts predicted

Upside of 338.84%

Current:

$3.57

Target:

$15.67

Insights on Aprea Therapeutics Inc

Price Movement
In the last 3 years, APRE stock has moved down by -96.2%
APRE vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 48.1% return, outperforming this stock by 62.3%
APRE vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 46.0% return, outperforming this stock by 142.2%
Price to Sales
ForAPRE every $1 of sales, investors are willing to pay $12.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $15.5 for every $1 of sales.

Aprea Therapeutics Inc Technicals Summary

Sell

Neutral

Buy

Aprea Therapeutics Inc is currently in a neutral trading position according to technical analysis indicators.

Aprea Therapeutics Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Aprea Therapeutics Inc	-10.23%	-29.15%	-20.8%	-95.82%	-99.6%
Regeneron Pharmaceuticals, Inc.	-7.0%	-24.01%	-9.49%	16.32%	106.34%
Biontech Se	9.3%	20.28%	18.26%	-57.29%	298.26%
Alnylam Pharmaceuticals, Inc.	-10.01%	60.97%	47.33%	35.08%	108.78%
Vertex Pharmaceuticals Incorporated	-8.33%	-4.49%	29.09%	120.96%	108.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Aprea Therapeutics Inc	0.48	NA	NA	-2.41	-0.5	-0.3	NA	4.54
Regeneron Pharmaceuticals, Inc.	18.56	18.56	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Aprea Therapeutics Inc	Buy	$16.9M	-99.6%	0.48	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$82.9B	106.34%	18.56	33.61%
Biontech Se	Buy	$28.5B	298.26%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	108.78%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$118.4B	108.53%	32.84	-4.51%

About Aprea Therapeutics Inc

annan naturvetenskaplig och teknisk forskning och utveckling

Organization	Aprea Therapeutics Inc
Employees	7
CEO	Dr. Oren Gilad Ph.D.
Industry	Commercial Services

Management People of Aprea Therapeutics Inc

Name	Title
Dr. Oren Gilad Ph.D.	Co-Founder, CEO, President & Director
Mr. John P. Hamill CPA	Senior VP, CFO, Principal Accounting Officer & Secretary
Dr. Dansu Li Ph.D.	Head of Technology
Dr. Lars B. Abrahmsen Ph.D.	Senior VP & Chief Scientific Officer
Mr. Brian Wiley	Senior Vice President of Corporate Development & Strategy
Dr. Michel Afargan Ph.D.	Head of Pharmacology Development
Mr. Ze'ev Weiss B.Sc., C.P.A.	Chief Business Advisor
Dr. Nadeem Q. Mirza M.D., M.P.H.	Executive Officer
Ms. Andrea Epstein	Controller

Important FAQs about investing in Aprea Therapeutics Inc from India :

What is Aprea Therapeutics Inc share price today?

Aprea Therapeutics Inc (APRE) share price today is $3.57.

Can Indians buy Aprea Therapeutics Inc shares?

Yes, Indians can invest in the Aprea Therapeutics Inc (APRE) from India.

With INDmoney, you can buy Aprea Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Aprea Therapeutics Inc at zero transaction cost.

How can I buy Aprea Therapeutics Inc shares from India?

It is very easy to buy Aprea Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aprea Therapeutics Inc be purchased?

Yes, you can buy fractional shares of Aprea Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Aprea Therapeutics Inc stocks?

To start investing in Aprea Therapeutics Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.